يعرض 1 - 20 نتائج من 4,916 نتيجة بحث عن '"TÉCNICAS Y EQUIPOS ANALÍTICOS"', وقت الاستعلام: 0.69s تنقيح النتائج
  1. 1
    Conference
  2. 2
    Conference

    المساهمون: Nieto Ortiz A, Turró Garriga O, Fontova Almató A, Plaja Roman P Institut de Recerca Glòria Compte, Fundació Salut Empordà, Figueres, Spain. Aguilera Majoral E, Juvanet Ribot J Servei d'oftalmologia, Hospital de Figueres, Fundació Salut Empordà, Figueres, Spain, Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: XXIV Jornada de la Societat Catalana de Qualitat Assistencial; 2024-06; Girona; Nieto Ortiz A, Aguilera Majoral E, Turró Garriga O, Juvanet Ribot J, Fontova Almató A, Plaja Roman P. e-Visió: Una nova app de cribratge visual per millorar la qualitat assistencial de la unitat d’Oftalmologia. Pòster presentat a: XXIV Jornada de la Societat Catalana de Qualitat Assistencial; 2024 juny 5-6; Girona.; https://hdl.handle.net/11351/11830

  3. 3
    Book

    المساهمون: Departament de Salut

    المصدر: Scientia

    Time: 11, 16, 18

    وصف الملف: application/pdf

    Relation: Manual de vacunacions de Catalunya.; Vacuna anti-virus del papil·loma humà (vacuna VPH). A: Manual de vacunacions de Catalunya. Barcelona: Agència de Salut Pública de Catalunya; 2024. p.163-169.; https://hdl.handle.net/11351/11454

  4. 4
    Academic Journal

    المساهمون: Institut Català de la Salut, Asokan KL, Landes JR University of Texas Health Science Center at Houston TX. Renders W, Muiño Mosquera L, De Backer J Ghent University Hospital Ghent Belgium. Jantzen DW University of Nebraska Medical Center Omaha NE. Teixido-Tura G, Evangelista A Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of the American Heart Association;13(21); https://doi.org/10.1101/2024.05.06.24306968; Asokan KL, Landes JR, Renders W, Muiño Mosquera L, De Backer J, Jantzen DW, et al. Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium. J Am Heart Assoc. 2024 Nov 5;13(21):e036274.; https://hdl.handle.net/11351/12308; 001348016100001

  5. 5
    Academic Journal

    المساهمون: Institut Català de la Salut, Guarch-Ibáñez B Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain. Universitat de Girona (UDG), Girona, Catalonia, Spain. Congenital Infections Working Group, Spanish Society of Pediatric Infectious Diseases (SEIP), Spain. Carreras-Abad C Congenital Infections Working Group, Spanish Society of Pediatric Infectious Diseases (SEIP), Spain. Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Frick MA Congenital Infections Working Group, Spanish Society of Pediatric Infectious Diseases (SEIP), Spain. Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Blázquez-Gamero D Congenital Infections Working Group, Spanish Society of Pediatric Infectious Diseases (SEIP), Spain. Pediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Spain. Baquero-Artigao F Congenital Infections Working Group, Spanish Society of Pediatric Infectious Diseases (SEIP), Spain. Pediatric Infectious Diseases Unit, Hospital Universitario La Paz, Madrid, Spain. Universidad Autónoma de Madrid, Madrid, Spain. CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain. Fuentes I Toxoplasmosis and Intestinal Protozoa Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain. Soler-Palacin P Unitat de Patologia Infecciosa i Immunodeficiències de Pediatria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: PLOS Neglected Tropical Diseases;18(10); https://doi.org/10.1371/journal.pntd.0012619; https://hdl.handle.net/11351/12305; 001340301400001

  6. 6
    Academic Journal

    المساهمون: Institut Català de la Salut, Saini KS Fortrea Inc., Durham, NC, United States. Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. Somara S, Thatai P Fortrea Inc., Durham, NC, United States. Ko HC, Wallen ZD Labcorp Oncology, Durham, NC, United States. Quintana A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Frontiers in Oncology;14; https://doi.org/10.3389/fonc.2024.1473706; Saini KS, Somara S, Ko HC, Thatai P, Quintana A, Wallen ZD, et al. Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy. Front Oncol. 2024 Oct 8;14:1473706.; https://hdl.handle.net/11351/12309; 001337479900001

  7. 7
    Academic Journal

    المساهمون: Institut Català de la Salut, Valdés N Endocrinology & Nutrition Department, Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain. Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, CIBERDEM, CIBERER, Endo-ERN, Barakaldo, Spain. Romero A Endocrinology & Nutrition Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Diego E Endocrinology & Nutrition Department, Hospital Universitario Cruces, Barakaldo, Spain. Calatayud M Endocrinology & Nutrition Department, Hospital Universitario Doce de Octubre, Madrid, Spain. Lamas C Endocrinology & Nutrition Department, Hospital Universitario de Albacete, Albacete, Spain. Araujo-Castro M Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. Casterás A Servei d’Endocrinologia i Nutrició, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Frontiers in Endocrinology;15; https://doi.org/10.3389/fendo.2024.1427821; https://hdl.handle.net/11351/12306; 001339674500001

  8. 8
    Academic Journal

    المساهمون: Institut Català de la Salut, Martos-Guillami N, Llorens-Cebrià C, Martínez-Díaz I, Gonçalves F, Muñoz V, León-Román J, Vilardell-Vilà J Grup de Recerca de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vergara A, Bermejo S, Soler MJ Grup de Recerca de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (RD21/0005/0016), Madrid, Spain. Motto AE Grup de Recerca de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Laboratory of Physiology/ Pharmacology, Unit of Pathophysiology, Bioactive Substances and Safety, Faculty of Sciences, University of Lomé, Lomé, Togo. Garcias-Ramis MM, Allo-Urzainqui E, Ferrer-Costa RR Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Narváez A Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Jacobs-Cachá C Grup de Recerca de Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS), Instituto de Salud Carlos III (RD21/0005/0016), Madrid, Spain. Servei de Bioquímica Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Rates (Animals de laboratori), Insuficiència renal crònica - Tractament, Nefropaties diabètiques - Tractament, Farmacologia renal, Avaluació de resultats (Assistència sanitària), DISEASES::Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Nephropathies, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Sodium-Glucose Transporter 2 Inhibitors, DISEASES::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Renal Insufficiency, Chronic::Kidney Failure, Chronic, CHEMICALS AND DRUGS::Pharmaceutical Preparations::Drug Combinations, ORGANISMS::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Eutheria::Rodentia::Muridae::Murinae::Mice, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::nefropatías diabéticas, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores del cotransportador de sodio-glucosa 2, ENFERMEDADES::enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::insuficiencia renal::insuficiencia renal crónica::fallo renal crónico, COMPUESTOS QUÍMICOS Y DROGAS::preparados farmacéuticos::combinaciones de fármacos, ORGANISMOS::Eukaryota::animales::Chordata::vertebrados::mamíferos::Eutheria::Rodentia::Muridae::Murinae::ratas, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

    وصف الملف: application/pdf

    Relation: Frontiers in Pharmacology;15; https://doi.org/10.3389/fphar.2024.1415879; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI21%2F01292; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/CM23%2F00213; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/FI22%2F00335; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/AC22%2F00029; https://hdl.handle.net/11351/12302

  9. 9
    Academic Journal

    المساهمون: Institut Català de la Salut, Martínez-Campreciós J, Aznar ML, Espinosa-Pereiro J, Molina I Unitat de Medicina Tropical i Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades, Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. Zacarias A, Terán R Tuberculosis Unit, Hospital Nossa Senhora da Paz, Cubal, Benguela, Angola. Nindia A Laboratory Department, Hospital Nossa Senhora da Paz, Cubal, Benguela, Angola. Aixut S Unitat de Medicina Tropical i Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Tuberculosis Unit, Hospital Nossa Senhora da Paz, Cubal, Benguela, Angola. Sulleiro E, Tórtola MT Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Sánchez-Montalvá A Unitat de Medicina Tropical i Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades, Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. Grupo de Estudio de micobacterias, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Infection;89(6); https://doi.org/10.1016/j.jinf.2024.106291; https://hdl.handle.net/11351/12303; 001353404500001

  10. 10
    Academic Journal

    المساهمون: Institut Català de la Salut, Popat R NIHR UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, UK. Augustson B Sir Charles Gairdner Hospital and Linear Clinical Research, Perth, WA, Australia. Gironella M Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Lee C Royal Adelaide Hospital, Adelaide, SA, Australia. Cannell P Department of Haematology, Fiona Stanley Hospital, Perth, WA, Australia. Patel N GSK, London, UK, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Mieloma múltiple - Tractament, Quimioteràpia combinada, Anticossos monoclonals - Ús terapèutic, Glucocorticoides - Ús terapèutic, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Plasma Cell::Multiple Myeloma, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized, CHEMICALS AND DRUGS::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones::Glucocorticoids, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de células plasmáticas::mieloma múltiple, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados, COMPUESTOS QUÍMICOS Y DROGAS::hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal::glucocorticoides

    وصف الملف: application/pdf

    Relation: Blood Cancer Journal;14; https://doi.org/10.1038/s41408-024-01155-y; https://hdl.handle.net/11351/12304; 001339918000002

  11. 11
    Academic Journal

    المساهمون: Institut Català de la Salut, Gascón A, Maiz N, Mendoza M, del Barco E, Carreras E, Goya M Unitat de Medicina Fetal, Servei d’Obstetrícia, Vall d′Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Brik M Department of Obstetrics, Hospital Universitario de Torrejón, Universidad Francisco de Vitoria, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Obstetrics & Gynecology and Reproductive Biology: X;24; https://doi.org/10.1016/j.eurox.2024.100347; https://hdl.handle.net/11351/12300; 001049965200001

  12. 12
    Academic Journal

    المساهمون: Institut Català de la Salut, Tagliabue S ICFO–Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Biomedical Optics, Barcelona, Spain. Kacprzak M ICFO–Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Biomedical Optics, Barcelona, Spain. Nalecz Institute of Biocybernetics and Biomedical Engineering, Warsaw, Poland. Rey-Perez A, Baena J, Riveiro M Unitat de Recerca en Neurotraumatologia i Neurocirurgia, Vall d’Hebron Hospital, Barcelona, Spain. Maruccia F ICFO–Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Biomedical Optics, Barcelona, Spain. Unitat de Recerca en Neurotraumatologia i Neurocirurgia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Poca MA Unitat de Recerca en Neurotraumatologia i Neurocirurgia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Neurocirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Neurophotonics;11(4); https://doi.org/10.1117/1.NPh.11.4.045005; info:eu-repo/grantAgreement/EC/H2020/675332; info:eu-repo/grantAgreement/EC/H2020/101017113; info:eu-repo/grantAgreement/EC/H2020/871124; https://hdl.handle.net/11351/12301

  13. 13
    Academic Journal

    المساهمون: Institut Català de la Salut, Agostinetto E Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium. Bruzzone M U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Hamy AS Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France. Kim HJ Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Chiodi C Cancer Survivorship Program – Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France. Bernstein-Molho R Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel. Carrasco E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hereditary Cancer Genetics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  14. 14
    Academic Journal

    المساهمون: Institut Català de la Salut, Burgos J, Benítez-Martínez A, Mancebo C, Massana N, Astorga-Gamaza A, Curran A, Garcia-Perez JN, Falcó V, Buzón MJ, Genescà M Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Castellvi J, Landolfi S Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Ciències Morfològiques, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: JCI Insight;9(15); https://doi.org/10.1172/jci.insight.175251; info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F00736; info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F00160; info:eu-repo/grantAgreement/ES/PE2017-2020/RD16%2F0025%2F0007; info:eu-repo/grantAgreement/ES/PE2017-2020/GLD18%2F00008; Burgos J, Benítez-Martínez A, Mancebo C, Massana N, Astorga-Gamaza A, Castellvi J, et al. Intraepithelial CD15 infiltration identifies high grade anal dysplasia in people with HIV. JCI Insight. 2024 Aug 8;9(15):e175251.; https://hdl.handle.net/11351/11861

  15. 15
    Academic Journal

    المساهمون: Institut Català de la Salut, Candal-Pedreira C Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Spain. Díaz-Pérez D Department of Pulmonology and Thoracic Surgery/Research Unit, Nuestra Señora de Candelaria University Teaching Hospital, Santa Cruz de Tenerife, Spain. Velasco V Pediatric Pulmonology, Canary Islands University Teaching Hospital, Tenerife, Spain. Casanova C Department of Pulmonology/Research Unit, Nuestra Señora de Candelaria University Teaching Hospital, La Laguna University, Tenerife, Spain. Acosta O Department of Pulmonology, Canary Islands University Teaching Hospital, La Laguna, Santa Cruz de Tenerife, Spain. Peces-Barba G Department of Pulmonology, Fundación Jiménez Díaz University Teaching Hospital, Madrid, Spain. Consortium for Biomedical Research in Respiratory Diseases (CIBER de Enfermedades Respiratorias/CibeRes), Madrid, Spain. Cruz Carmona MJ Consortium for Biomedical Research in Respiratory Diseases (CIBER de Enfermedades Respiratorias/CibeRes), Madrid, Spain. Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Muñoz X Consortium for Biomedical Research in Respiratory Diseases (CIBER de Enfermedades Respiratorias/CibeRes), Madrid, Spain. Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Archivos de Bronconeumología;60(8); https://doi.org/10.1016/j.arbres.2024.05.002; Candal-Pedreira C, Díaz-Pérez D, Velasco V, Casanova C, Acosta O, Peces-Barba G, et al. Lung Function and Symptoms of Exposure to the Volcanic Eruption in the Canary Islands: First Follow-Up of the ASHES Study. Arch Bronconeumol. 2024 Aug;60(8):475–82.; https://hdl.handle.net/11351/11855

  16. 16
    Academic Journal

    المساهمون: Institut Català de la Salut, Munté E Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain. Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain. Feliubadaló L, Del Valle J Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain. Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain. Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain. González S Hereditary Cancer Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain. Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain. Ramos-Muntada M Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d’Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Spain. Ciber Oncología, Instituto Salud Carlos III, Madrid, Spain. Balmaña J High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: The Journal of Molecular Diagnostics;26(8); https://doi.org/10.1016/j.jmoldx.2024.05.005; Munté E, Feliubadaló L, Del Valle J, González S, Ramos-Muntada M, Balmaña J, et al. Open-source bioinformatic pipeline to improve PMS2 genetic testing using short-read NGS data. J Mol Diagnostics. 2024 Aug;26(8):727–38.; https://hdl.handle.net/11351/11852; 001279922100001

  17. 17
    Academic Journal

    المساهمون: Institut Català de la Salut, Szeimies RM Department of Dermatology & Allergology, Klinikum Vest GmbH Academic Teaching Hospital, Recklinghausen, Germany. Ulrich C GmbH & Department of Dermatology, Collegium Medicum, Charité Universitätsmedizin, Berlin, Germany. Ferrándiz-Pulido C Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Hofbauer GFL Universität Zürich, Zurich, Switzerland. Dermatologische Klinik, Universitätsspital Zürich, Zurich, Switzerland. Lear JT Department of Dermatology, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK. Manchester Academic Health Science Centre, Manchester, UK. Lebbé C Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, INSERM U976, Université Paris Cite, Paris, France, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Dermatology and Therapy;14; https://doi.org/10.1007/s13555-024-01215-y; Szeimies RM, Ulrich C, Ferrándiz-Pulido C, Hofbauer GFL, Lear JT, Lebbé C, et al. The “Personalising Actinic Keratosis Treatment for Immunocompromised Patients” (IM-PAKT) Project: An Expert Panel Opinion. Dermatol Ther (Heidelb). 2024 Jun;14:1739–1753.; https://hdl.handle.net/11351/11860; 001251083200001

  18. 18
    Academic Journal

    المساهمون: Institut Català de la Salut, Avellaneda N Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. General Surgery Department, CEMIC, Buenos Aires, Argentina. Pellino G Department of Advanced Medical and Surgical Sciences, Università Degli Studi Della Campania “Luigi Vanvitelli”, Naples, Italy. Unitat de Cirurgia de Còlon i Recte, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Maroli A Division of Colon and Rectal Surgery, IRCCS – Humanitas Research Hospital, Milan, Italy. Department of Biomedical Sciences, Humanitas University, Milan, Italy. Tottrup A Department of Surgery, Aarhus University Hospital, Aarhus, Denmark. Bislenghi G, Colpaert J Colorectal Surgery Department, Leuven University Hospital, Leuven, Belgium, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Colorectal Disease;26(7); https://doi.org/10.1111/codi.17056; Avellaneda N, Pellino G, Maroli A, Tottrup A, Bislenghi G, Colpaert J, et al. Short-term outcomes of surgical treatment for primary ileocaecal Crohn’s disease: Results of the Crohn’s(urg) study, a multicentre, retrospective, comparative analysis between inflammatory and complicated phenotypes. Color Dis. 2024 Jul;26(7):1415–27.; https://hdl.handle.net/11351/11851; 001243460900001

  19. 19
    Academic Journal

    المساهمون: Institut Català de la Salut, Navarro P Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain. Instituto de Investigación Sanitaria de Castilla‐La Mancha (IDISCAM), Toledo, Spain. Instituto de Investigación Sanitaria La Princesa, Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain. Feo‐Ortega S Instituto de Investigación Sanitaria de Castilla‐La Mancha (IDISCAM), Toledo, Spain. Department of Pediatrics, Hospital General de Tomelloso, Tomelloso, Spain. Casabona‐Francés S Instituto de Investigación Sanitaria La Princesa, Madrid, Spain. Department of Gastroenterology, Hospital Universitario de La Princesa, Madrid, Spain. Gutiérrez‐Junquera C Pediatric Gastroenterology Unit, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Universidad Autónoma de Madrid, Madrid, Spain. Savarino EV Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. Gastroenterology Unit, Azienza Ospedaliera di Padova, Padua, Italy. Amorena E Department of Gastroenterology, Hospital Universitario de Navarra, Pamplona, Spain. Guagnozzi D Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, CIBERehd, Madrid, Spain. Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: European Journal of Pediatrics;183; https://doi.org/10.1007/s00431-024-05618-z; Navarro P, Feo‐Ortega S, Casabona‐Francés S, Gutiérrez‐Junquera C, Savarino EV, Amorena E, et al. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry. Eur J Pediatr. 2024 Aug;183:3567–3578.; https://hdl.handle.net/11351/11857; 001236501800002

  20. 20
    Academic Journal

    المساهمون: Institut Català de la Salut, Montoro J Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Department of Hematology, Universidad Católica de Valencia, Valencia, Spain. Ngoya M Department of Biostatistics, EBMT Lymphoma Working Party, Paris, France. Kulagin A RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russia. Giebel S Department of Bone Marrow Transplantation and Oncohematology, Fundacja Na Ratunek Dzieciom z Chorobą Nowotworową, Gliwice, Poland. Broers AEC Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Bramanti S IRCCS Humanitas Research Hospital, Transplantation Unit Department of Oncology and Haematology, Milan, Italy. Fox L Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Inhibidors enzimàtics - Ús terapèutic, Empelt contra l'hoste, Malaltia de l', Cèl·lules mare hematopoètiques - Trasplantació, Hodgkin, Malaltia de - Tractament, DISEASES::Hemic and Lymphatic Diseases::Lymphatic Diseases::Lymphoproliferative Disorders::Lymphoma::Hodgkin Disease, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Cell Transplantation::Stem Cell Transplantation::Hematopoietic Stem Cell Transplantation, DISEASES::Immune System Diseases::Graft vs Host Disease, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Calcineurin Inhibitors, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades linfáticas::trastornos linfoproliferativos::linfoma::enfermedad de Hodgkin, Otros calificadores::Otros calificadores::/terapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de células::trasplante de células madre::trasplante de células madre hematopoyéticas, ENFERMEDADES::enfermedades del sistema inmune::enfermedad injerto contra huésped, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de calcineurina

    وصف الملف: application/pdf

    Relation: Blood Advances;8(15); https://doi.org/10.1182/bloodadvances.2024013328; Montoro J, Ngoya M, Kulagin A, Giebel S, Broers AEC, Bramanti S, et al. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Adv. 2024 Aug 13;8(15):3985–3992.; https://hdl.handle.net/11351/11856; 001226910500001